Abstract
Background and ImportanceIn Italy, patient (pt) access to oncological drugs is provided by the NHS, following authorisation by the European Medicines Agency (EMA) and negotiation with the Italian Medicines Agency...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
